Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-031719
Filing Date
2025-10-24
Accepted
2025-10-24 16:02:41
Documents
19
Period of Report
2025-12-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A aytu20250915_def14a.htm   iXBRL DEF 14A 725880
6 card01.jpg GRAPHIC 241124
7 card02.jpg GRAPHIC 183542
8 netloss.jpg GRAPHIC 76273
9 tsr2026.jpg GRAPHIC 75003
  Complete submission text file 0001437749-25-031719.txt   2692835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aytu-20250630.xsd EX-101.SCH 4557
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20250630_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20250630_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20250630_pre.xml EX-101.PRE 714
21 EXTRACTED XBRL INSTANCE DOCUMENT aytu20250915_def14a_htm.xml XML 118513
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 251416150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)